Key Events This Week
10 Aug: Stock opens at Rs.1,070, declines 0.28%
11 Aug: Sharp 2.80% drop amid lower volumes
12 Aug: Open interest surges 11.9% as price falls 3.08%
13 Aug: Minor recovery with 0.11% gain
14 Aug: Mixed quarterly results released; stock closes at Rs.1,010 (+0.09%)
10 August: Week Begins with Mild Decline Despite Sensex Gains
Max Healthcare opened the week at Rs.1,070.00 on 10 August 2026, closing down 0.28% from the previous Friday’s close. This decline contrasted with the Sensex’s modest 0.09% gain to 37,131.97 points, signalling early weakness in the stock. Trading volume was robust at 801,980 shares, indicating active participation despite the slight price fall.
11 August: Accelerated Sell-Off Amid Lower Volumes
The stock experienced a sharper decline on 11 August, dropping 2.80% to close at Rs.1,040.00. This underperformance was more pronounced than the Sensex’s 0.28% fall to 37,029.82 points. Volume declined to 411,046 shares, suggesting reduced buying interest as the stock faced selling pressure. This day marked the beginning of a sustained downtrend that would continue into midweek.
12 August: Derivatives Activity Surges as Price Drops 3.08%
On 12 August, Max Healthcare’s stock price fell further by 3.08% to Rs.1,008.00, underperforming the Sensex’s 0.17% decline. Notably, the derivatives market saw a sharp 11.9% increase in open interest, rising from 33,337 to 37,298 contracts. This surge in open interest, coupled with a high volume of 35,476 contracts traded, indicated heightened market activity despite the bearish price action.
The stock’s futures value was approximately ₹17,052.9 lakhs, and the options segment reflected a notional value of ₹17,855.15 crores, culminating in a combined derivatives market value of ₹20,035.6 lakhs. This activity suggests that investors were increasingly positioning for further downside or hedging existing positions amid a weak technical backdrop.
Technically, the stock traded below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — reinforcing the bearish momentum. The Hospital & Healthcare Services sector also declined by 2.57% on the day, adding sectoral pressure to the stock’s performance.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
13 August: Slight Recovery Amid Mixed Market Sentiment
Following three consecutive days of decline, Max Healthcare posted a marginal gain of 0.11% on 13 August, closing at Rs.1,009.10. This minor uptick contrasted with the Sensex’s 0.16% rise to 37,024.45 points. Trading volume was relatively low at 225,561 shares, reflecting cautious investor sentiment. The narrow price movement suggested a temporary equilibrium between buyers and sellers after the steep falls earlier in the week.
14 August: Mixed Quarterly Results Released; Stock Ends Week Near Rs.1,010
On 14 August, Max Healthcare reported mixed quarterly results for the quarter ended June 2026. The company achieved record net sales of ₹2,366.17 crores, marking a significant top-line milestone. However, profitability metrics deteriorated, with profit after tax declining 12.8% to ₹322.96 crores compared to the previous four-quarter average.
The operating profit to interest ratio dropped to 8.43 times, the lowest level in recent periods, reflecting rising interest costs that increased by 21.19% to ₹137.66 crores over six months. These factors contributed to a shift in the company’s financial trend score from +5 to -6, signalling emerging operational challenges.
The stock closed at Rs.1,010.00, up 0.09% on the day but down 5.87% for the week. The Sensex declined 0.17% to 36,962.93 points. Despite the mixed results, Max Healthcare’s Mojo Score was upgraded to 50.0 with a Hold rating, indicating a cautious but more balanced outlook amid near-term headwinds.
Holding Max Healthcare Institute Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-10 | Rs.1,070.00 | -0.28% | 37,131.97 | +0.09% |
| 2026-08-11 | Rs.1,040.00 | -2.80% | 37,029.82 | -0.28% |
| 2026-08-12 | Rs.1,008.00 | -3.08% | 36,967.15 | -0.17% |
| 2026-08-13 | Rs.1,009.10 | +0.11% | 37,024.45 | +0.16% |
| 2026-08-14 | Rs.1,010.00 | +0.09% | 36,962.93 | -0.17% |
Key Takeaways
Bearish Derivatives Activity: The 11.9% surge in open interest on 12 August amid falling prices indicates increased bearish positioning or hedging, signalling investor caution on near-term prospects.
Mixed Financial Results: Record quarterly sales demonstrate growth potential, but declining profit after tax and rising interest costs highlight margin pressures and operational challenges.
Technical Weakness: Trading below all major moving averages and underperforming both the sector and Sensex reflects a weak momentum environment for the stock.
Mojo Grade Upgrade: The upgrade to a Hold rating with a Mojo Score of 50.0 suggests some improvement in fundamentals, though risks remain elevated.
Liquidity and Investor Engagement: Increased delivery volumes and active derivatives trading provide sufficient liquidity for institutional and retail participation, enabling tactical positioning.
Conclusion
Max Healthcare Institute Ltd’s performance over the week ending 14 August 2026 was characterised by a significant price decline of 5.87%, markedly underperforming the broader market. The week’s key drivers included a sharp rise in derivatives open interest amid bearish price action and a mixed quarterly earnings report that revealed operational and margin pressures despite record sales. While the Mojo Grade upgrade to Hold offers a cautiously optimistic signal, the prevailing technical weakness and sectoral headwinds counsel prudence. Investors should closely monitor upcoming financial updates and open interest trends to better understand the stock’s directional trajectory in the near term.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
